Literature DB >> 26648601

Janus kinase inhibitors - holistically seeing two faces.

John A Loudon1.   

Abstract

Year:  2015        PMID： 26648601      PMCID： PMC4654041          DOI： 10.18773/austprescr.2015.006

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  4 in total

1.  STAT3 signaling after traumatic brain injury.

Authors:  Anthony A Oliva; Yuan Kang; Juliana Sanchez-Molano; Concepción Furones; Coleen M Atkins
Journal:  J Neurochem       Date:  2012-01-31       Impact factor: 5.372

Review 2.  Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.

Authors:  Yasushi Fujio; Makiko Maeda; Tomomi Mohri; Masanori Obana; Tomohiko Iwakura; Akiko Hayama; Tomomi Yamashita; Hiroyuki Nakayama; Junichi Azuma
Journal:  J Pharmacol Sci       Date:  2011-11-05       Impact factor: 3.337

Review 3.  A novel prosurvival model for cancer under environmental challenge: the "heart-felt" message for therapeutic intervention.

Authors:  John A Loudon
Journal:  Oncol Res       Date:  2011       Impact factor: 5.574

Review 4.  Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects.

Authors:  P Fischer; D Hilfiker-Kleiner
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.